By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pernix Therapeutics, Inc. 

P.O. Box 40

Gonzales  Louisiana  70707-0040  U.S.A.
Phone: 800-793-2145 Fax:



Company News
Pernix (PTX) Announces The Issuance Of Zohydro ER With BeadTek Formulation Patent 9/24/2015 8:12:36 AM
Pernix (PTX) Presents Data On Novel Extended Release Formulation Of Hydrocodone Bitartrate At PAINWeek 9/9/2015 1:38:03 PM
Pernix (PTX) To Present At Morgan Stanley Global Healthcare Conference 9/9/2015 10:46:01 AM
Pernix (PTX) Announces New Revolving Credit Facility 8/24/2015 10:23:36 AM
Pernix (PTX) Reports Second Quarter 2015 Financial Results 8/6/2015 2:03:49 PM
Pernix (PTX) To Report Second Quarter 2015 Financial Results On Thursday, August 6, 2015 7/27/2015 7:48:52 AM
Pernix (PTX) Releases Positive In Vitro Abuse Deterrent Data For Third Generation Extended Release Hydrocodone ZX007 7/27/2015 7:22:07 AM
Pernix (PTX) To Present At JMP Securities Life Sciences Conference 6/16/2015 10:41:23 AM
Pernix (PTX) To Present At Jefferies and Co. 2015 Healthcare Conference 5/21/2015 11:51:10 AM
Pernix (PTX) Release: FDA Approves TREXIMET (Sumatriptan And Naproxen Sodium) For Use In Pediatric Patients 5/15/2015 9:21:44 AM